Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Pei Shen Huang"'
Autor:
Yi-Fen Chiang, Ko-Chieh Huang, Tsui-Chin Huang, Hsin-Yuan Chen, Mohamed Ali, Ayman Al-Hendy, Pei-Shen Huang, Shih-Min Hsia
Publikováno v:
Redox Biology, Vol 78, Iss , Pp 103411- (2024)
Uterine leiomyoma (UL), commonly referred to as benign tumors, is characterized by excessive cell proliferation, extracellular matrix (ECM) accumulation, and the presence of stem cell-like properties. Nicotinamide adenine dinucleotide (NAD+) metaboli
Externí odkaz:
https://doaj.org/article/593bac45e12141c9921938543b405590
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 58, Iss 3, Pp 313-317 (2019)
Objective: Anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis is a paraneoplastic syndrome associated with ovarian teratomas. Anti-NMDAR encephalitis patients typically present with prominent psychiatric symptoms, seizures, and involuntary
Externí odkaz:
https://doaj.org/article/ca610024cb3444c19d9345ca219ac879
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 53, Iss 3, Pp 392-396 (2014)
Objective: To investigate the possible causes of iatrogenic parasitic myoma and methods to prevent its occurrence. Case report: A 27-year-old nulliparous unmarried patient underwent laparoscopic myomectomy with morcellation for a submucosal myoma at
Externí odkaz:
https://doaj.org/article/3d69bf2953d44a048cbf27879a456636
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 58, Iss 3, Pp 313-317 (2019)
Objective: Anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis is a paraneoplastic syndrome associated with ovarian teratomas. Anti-NMDAR encephalitis patients typically present with prominent psychiatric symptoms, seizures, and involuntary
Publikováno v:
Journal of Minimally Invasive Gynecology. 23:954-961
Study Objective Intraligamental myomas (IMs) represent 6% to 10% of all uterine myomas. An IM growing from the lateral uterine wall into the broad ligament often presents as a large pelvic mass without symptoms. Removing a large IM can be difficult b
Publikováno v:
Journal of Minimally Invasive Gynecology. 22:992-996
To evaluate the efficacy of gonadotropin-releasing hormone analogue (GnRHa) use before laparoscopic myomectomy (LM) in large myomas.Prospective study (Canadian Task Force classification II-1).University-affiliated hospital.Ninety-one women with large
Paclitaxel is used as an adjuvant to enhance the effectiveness of ionization radiation therapy; however, high-energy radiation often damages the healthy cells surrounding cancer cells. Low-energy, middle-infrared radiation (MIR) has been shown to pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee0b58b0e0243cda74bc20df195b618a
Autor:
Li Yun Chou, Peng-Hui Wang, Pei Shen Huang, Daw Yuan Chang, Bor-Ching Sheu, Su-Cheng Huang, Szu-Yu Chen, Wen-Chun Chang
Publikováno v:
Journal of Minimally Invasive Gynecology. 19:715-721
To evaluate the efficacy of laparoscopic uterine artery ligation (LUAL) before in situ morcellation (ISM) compared with ISM alone.Prospective study (Canadian Task Force classification II-1).University-affiliated hospital.One hundred forty-four women
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 26(1)
ObjectiveTo determine the functional attributes of CD4+ CD25+ regulatory T (Treg) cells by suppressing natural killer (NK) cell activity in human cervical cancer (CC).MethodsTriple-color flow cytometry was used to study the phenotypic expression of C
Enhancement of Taxol effectiveness on HeLa cells by Selected broad Bandwidth infrared radiation (IR)
Autor:
Pei-Shen Huang, 黃佩慎
101
Cervical cancer is the third most common cancer in women, with an estimated 530 000 new cases in 2008. More than 85% of the global burden occurs in developing countries, where it accounts for 13% of all female cancers. High-risk regions are
Cervical cancer is the third most common cancer in women, with an estimated 530 000 new cases in 2008. More than 85% of the global burden occurs in developing countries, where it accounts for 13% of all female cancers. High-risk regions are
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/18909246871396696145